Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07211646 · ClinicalTrials.gov registry record · NA

The Assessment of Human Sleep and Its Functions

A NA study of Insomnia, sponsored by StimScience.

Active
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT07211646: Active NA study of Insomnia, sponsored by StimScience.

NCT07211646 is a NA study of Insomnia that is active but no longer recruiting, run by StimScience. The registered enrollment target is 1,000 participants, above the 164-participant average among 151 other Insomnia trials with a reported enrollment target (510% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07211646, a NA study of Insomnia, is active but no longer recruiting, sponsored by StimScience.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at the effects of targeted brain stimulation when falling asleep and on sleep quality.

Primary Outcome

Sleep efficiency (time slept as a percentage time spent in bed) changes across the different interventions for each subject and aggregate that across subjects

Conditions Studied

Interventions

  • OTHER sham tES
  • OTHER Fixed tES
  • OTHER Personalized tES

Study Locations (1)

California

  • StimScience - Berkeley

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2019-05-20
Est. Completion 2028-12
Phase NA
StimScience

1 total trials

What the registry record for NCT07211646 still lists

NCT07211646 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 164-participant average among 151 other Insomnia trials with a reported enrollment target (510% higher).

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which sham tES is the first listed.

NCT07211646 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07211646 about?

NCT07211646 is a clinical study titled "The Assessment of Human Sleep and Its Functions". The purpose of this study is to look at the effects of targeted brain stimulation when falling asleep and on sleep quality.

What is the current status of trial NCT07211646?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2019-05-20. Estimated completion is 2028-12.

What conditions does trial NCT07211646 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT07211646?

The interventions under investigation include: sham tES (OTHER), Fixed tES (OTHER), Personalized tES (OTHER).

Who is sponsoring clinical trial NCT07211646?

This trial is sponsored by StimScience, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07211646 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07211646's enrollment target sits among peer trials

1,000 3rd of 151 higher than 148 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07211646, the US trial registry maintained by the National Library of Medicine. NCT07211646 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.